GL1X · GenesisL1 explorer

MolNFT v1 · #52676 · protein

Cellular inhibition of checkpoint kinase 2 and potentiation of cytotoxic drugs by novel CHK2 inhibitor PV1019

2W7X · SERINE/THREONINE-protein kinase CHK2: “Cellular inhibition of checkpoint kinase 2 and potentiation of cytotoxic drugs by novel CHK2 inhibitor PV1019”. X-ray diffraction, 3 ligands (D1A, MG, NO3), 3 pockets (best druggability 0.64).…

PDB
2W7X
Type
protein
Length
285 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK2
EC
2.7.11.1
UniProt
O96017
Ligands
D1A, MG, NO3
Pockets
3 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK2 (EC 2.7.11.1)protein28541% helix, 18% strandO96017

Ligands and binding sites

  • D1A · N-[4-[(E)-N-carbamimidamido-C-methyl-carbonimidoyl]phenyl]-7-nitro-1H-indole-2-carboxamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • NO3 · Nitrate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12890.640.8140D1A
2890.340.7420empty
3780.330.7419empty

Compared structures

  • 2W7X · Cellular inhibition of checkpoint kinase 2 and potentiation of cytotoxic drugs by novel… · the same entry in another collection · chain A against A, TM-score 1.00
  • O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.